Congenital disorder of glycosylation with defective fucosylation 2 (FCSK gene defect): The third report in the literature with a mild phenotype

Mol Genet Genomic Med. 2023 Apr;11(4):e2117. doi: 10.1002/mgg3.2117. Epub 2022 Nov 24.

Abstract

Background: Congenital disorders of glycosylation (CDG) are a group of heterogeneous disorders caused by abnormal lipid or protein glycosylation. Variants in the FCSK gene have been reported to cause CDG. Defective FCSK-induced CDG (FCSK-CDG) has only been reported previously in three unrelated children.

Methods: In this study, we genetically and clinically examined a 3-year-old proband with resolved infantile spasms and normal development. Standard whole-exome sequencing (WES) and Sanger sequencing were performed to identify the functional impact of the variant.

Results: WES revealed a rare biallelic missense variant (c.3013G>C; p.Val1005Leu) in FCSK. RT-qPCR showed a significant depletion in FCSK gene expression in the affected individual. Western blotting revealed reduced FCSK expression at the protein level compared to that in the control. Furthermore, 3D protein modeling suggested changes in the secondary structure, which might affect the overall FCSK protein function.

Conclusion: This study broadens the mutation and phenotypic spectrum of FCSK-associated developmental disorders.

Keywords: FCSK; Fucokinase; Fucosylation; developmental delay; glycosylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Congenital Disorders of Glycosylation* / genetics
  • Exome*
  • Glycosylation
  • Humans
  • Mutation
  • Mutation, Missense
  • Phenotype